Epiqmax

EpiQMAx specializes in providing advanced mass spectrometry services focused on the measurement of histone epigenetic modifications and the characterization of antibodies and small molecules. The company serves pharmaceutical companies, clinics, and scientific laboratories, offering a fast and efficient service capable of simultaneously measuring up to 80 histone modifications. Results are delivered through easy-to-read plots and tables, ensuring clarity and accessibility for clients. EpiQMAx operates in the niche market of epigenetic services, leveraging its expertise in mass spectrometry to offer high-sensitivity and low-sample-requirement analyses. The business model revolves around offering specialized analytical services, generating revenue through service fees for their comprehensive reports and visualizations. Additionally, EpiQMAx provides tailored services for small molecule analysis, including purity and impurity analysis, pharmacokinetics, formulation studies, and assay development in lead discovery. The company's workflow is designed to meet the specific needs of its clients, ensuring high-quality and reliable results.

Keywords: mass spectrometry, histone modifications, epigenetic services, pharmaceutical analysis, antibody characterization, small molecule analysis, protein quantification, scientific labs, visual reports, high sensitivity.